Picture of SIGA Technologies logo

SIGA SIGA Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Momentum

Relative Strength (%)
1m+11.48%
3m+10.19%
6m-4.08%
1yr-33.82%
Volume Change (%)
10d/3m+53.89%
Price vs... (%)
52w High-53.31%
50d MA+4.29%
200d MA-14.99%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)6.13
PEG Ratio (f)0.3
EPS Growth (f)25.71%
Dividend Yield (f)9.52%
Valuation (ttm)IndustryMarket
Price to Book Value1.98
Price to Tang. Book1.99
Price to Free Cashflow8.78
Price to Sales3.08
EV to EBITDA3.86

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital31.96%
Return on Equity28.7%
Operating Margin50.45%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue$m124.96133.67110.78139.92138.72121.55237.4438.99%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+20.03-49.29+107.4-13.87-18.64+153.73n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of SIGA Technologies EPS forecast chart

Profile Summary

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
December 28th, 1995
Public Since
September 9th, 1997
No. of Shareholders
34
No. of Employees
46
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
71,436,927
Blurred out image of a map
Address
31 East 62Nd Street, NEW YORK, 10065
Web
https://www.siga.com/
Phone
+1 2126729100
Auditors
PricewaterhouseCoopers LLP

SIGA Share Price Performance

Upcoming Events for SIGA

Dividend For SIGA.OQ - 0.6000 USD

Q1 2025 SIGA Technologies Inc Earnings Release

SIGA Technologies Inc Annual Shareholders Meeting

Q2 2025 SIGA Technologies Inc Earnings Release

Similar to SIGA

Picture of 111 logo

111

us flag iconNASDAQ Global Market

Picture of ADMA Biologics logo

ADMA Biologics

us flag iconNASDAQ Global Market

Picture of ANI Pharmaceuticals logo

ANI Pharmaceuticals

us flag iconNASDAQ Global Market

Picture of Aquestive Therapeutics logo

Aquestive Therapeutics

us flag iconNASDAQ Global Market

Picture of Avadel Pharmaceuticals logo

Avadel Pharmaceuticals

us flag iconNASDAQ Global Market

FAQ